American Society of Clinical Oncology

SHERPA: White

People

  1. Hudis
    Hudis
  2. Goldfarb
    Goldfarb
  3. Lake
    Lake
  4. D'Andrea-Carlino
    D'Andrea-Carlino
  5. Modi
    Modi
  6. Dang
    Dang
  7. Fornier
    Fornier
  8. Gajria
    Gajria
  9. Robson
    Robson
  10. Chandarlapaty
    Chandarlapaty

Groups

  1. Biostatistics Service (12)
  2. Breast Medicine Service (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Solid Tumor Oncology Division (12)
  6. Survivorship Research (12)
  7. Population Sciences Research Program (10)
  8. Health Outcomes Research Group (8)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  10. GSK Faculty (6)
Search Within
  1. "Maura Dickler"
  2. "Sujata Patil"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
Groups
  1. Biostatistics Service (12)
  2. Breast Medicine Service (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Solid Tumor Oncology Division (12)
  6. Survivorship Research (12)

More Groups

People
  1. Maura Dickler (12)
  2. Sujata Patil (12)
  3. Clifford Hudis (11)
  4. Shari Goldfarb (8)
  5. Diana Lake (6)
  6. Gabriella D'Andrea-Carlino (5)

More People

Years
  1. 2015 (3)
  2. 2014 (2)
  3. 2013 (2)
  4. 2012 (2)
  5. 2010 (2)
  6. 2009 (1)
Publications
  1. Journal of Clinical Oncology (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
    Meeting Abstract

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M. E.; Moy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Monitoring PIK3CA mutant allele fraction (AF) in cell-free DNA (cfDNA) in metastatic breast cancer (MBC) patients treated with PI3K alpha-inhibitor plus letrozole (L) or exemestane (E)
    Meeting Abstract

    Moynahan, M. E.; Sung, P.; Asham, M.; Zamora, S.; Shah, P. D.; Modi, S.; Lake, D.; D'Andrea, G.; Goldfarb, S. B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Use of intravaginal 17-ß estradiol to improve sexual function and menopausal symptoms in postmenopausal women with breast cancer on aromatase inhibitors
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M. N.; Dnistrian, A. M.; Patil, S.; Dunn, L.; Chang, K.; Berkowitz, A. P.; Tucker, N.; Carter, J.; Barakat, R. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Fertility preservation options and the young breast cancer patient: A survey
    Meeting Abstract

    Junqueira, M. J.; Goldfarb, S. B.; Oppong, B. A.; Patil, S.; Eaton, A.; Olcese, C.; Morgan, J.; Kelvin, J. F.; Dickler, M. N.; Gemignani, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Traina, T. A.; Rugo, H. S.; Caravelli, J. F.; Patil, S.; Yeh, B.; Melisko, M. E.; Park, J. W.; Geneus, S.; Paulson, M.; Grothusen, J.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save